Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease

By Lapchak P.A.   Gash D.M.   Collins F.   Hilt D.   Miller P.J.   Araujo D.M.  

Experimental Neurology, Vol. 145, Iss. 2, 1997-06 ,pp. : 309-321

Elsevier

Access to resources Recommend Favorite

Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease

By Lapchak P.A.   Gash D.M.   Jiao S.   Miller P.J.   Hilt D.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 29-34

Elsevier

Access to resources Recommend Favorite

Mutation Analysis of the Glial Cell Line-Derived Neurotrophic Factor Gene in Parkinson's Disease

By Wartiovaara K.   Hytonen M.   Vuori M.   Paulin L.   Rinne J.   Sariola H.  

Experimental Neurology, Vol. 152, Iss. 2, 1998-08 ,pp. : 307-309

Elsevier

Access to resources Recommend Favorite

Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease

By Mandel R.J.   Snyder R.O.   Leff S.E.  

Experimental Neurology, Vol. 160, Iss. 1, 1999-11 ,pp. : 205-214

Elsevier

Access to resources Recommend Favorite

HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury

By Harvey B.K.   Chang C.F.   Chiang Y.H.   Bowers W.J.   Morales M.   Hoffer B.J.   Wang Y.   Federoff H.J.  

Experimental Neurology, Vol. 183, Iss. 1, 2003-09 ,pp. : 47-55

Elsevier

Access to resources Recommend Favorite